RR
Reshma Rangwala
CMO Karyopharm · University of Pennsylvania Health System
Credentials: · ·
History
Internal Medicine
Research
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
New England Journal of Medicine · 2016 · 8,389 citations
Pembrolizumab for the treatment of non-small-cell lung cancer
New England Journal of Medicine · 2015 · 5,237 citations
Journal of Clinical Oncology · 2017 · 447 citations
- GL
3 papers
3 papers
- RC
3 papers
- YC
3 papers · 3 as a resident
2 papers
2 papers
2 papers
2 papers
